> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Neurological Devices Panel Meeting on Alzheimer’s Device
- URL: https://www.fdaweb.com/neurological-devices-panel-meeting-on-alzheimers-device/
- Published: 2019-01-31T12:00:00.000Z
- Updated: 2026-09-15T00:59:27.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143270

*Federal Register* notice: FDA has announced a 3/21 Neurological Devices Panel of the Medical Devices Advisory Committee meeting. Panel members are scheduled to discuss and make recommendations on clinical information related to a *de novo* request for the NeuroAD Therapy System that was submitted by Neuronix. The device is intended to provide concurrent neurostimulation and cognitive training for the treatment of mild to moderate Alzheimer’s dementia. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-01-31/pdf/2019-00483.pdf?ref=fdaweb.com).